SCHEMBL1348975

SCHEMBL1348975

CCN(O)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.54
CNR2 P34972 1/20 0.53
LMNA P02545 1/20 0.53
ALDH1A1 P00352 3/20 0.52
MGLL Q99685 1/20 0.50
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
AOC3 Q16853 1/20 0.48
RIPK1 Q13546 1/20 0.47
TP53 P04637 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11353607 0.98 TSHR (0.52) TSHRCNR2LMNAALDH1A1MGLL
Propane SCHEMBL9330390 0.88 TSHR (0.54) TSHRCNR2LMNAALDH1A1MGLL
Ethane SCHEMBL8336264 0.85 TSHR (0.56) TSHRCNR2LMNAALDH1A1MGLL
SCHEMBL39645 0.85 CYP1A2 (0.55) TSHRCNR2LMNAALDH1A1MGLL
SCHEMBL10748300 0.82 CYP1A2 (0.53) TSHRCNR2LMNAALDH1A1MGLL
Hydrochloric Acid SCHEMBL1876474 0.82 CYP1A2 (0.53) TSHRCNR2LMNAALDH1A1MGLL
Ammonia Solution, Strong SCHEMBL28967895 0.82 CYP1A2 (0.53) TSHRCNR2LMNAALDH1A1MGLL
SCHEMBL7048042 0.82 TP53 (0.61) TSHRCNR2LMNAALDH1A1MGLL
SCHEMBL1239790 0.82 CYP1A2 (0.55) TSHRCNR2LMNAALDH1A1MGLL
SCHEMBL3804172 0.79 ALDH1A1 (0.52) LMNAALDH1A1CYP3A4TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106279162-A One-dimensional organic semiconductor nanowires/band that organophosphorus compound toxic gas is had fluorescence response and its preparation method and application 中国科学院化学研究所 2017-01-04 CN claimed
US-9221941-B2 Polyurethane elastomers made using mixtures of aliphatic diol chain extender and secondary amine DOW GLOBAL TECHNOLOGIES LLC (US) 2015-12-29 US claimed
EP-2649109-B1 POLYURETHANE ELASTOMERS MADE USING MIXTURES OF ALIPHATIC DIOL CHAIN EXTENDER AND SECONDARY AMINE DOW GLOBAL TECHNOLOGIES LLC (US) 2015-10-21 EP claimed
EP-2649109-A1 POLYURETHANE ELASTOMERS MADE USING MIXTURES OF ALIPHATIC DIOL CHAIN EXTENDER AND SECONDARY AMINE Dow Global Technologies LLC (US) 2013-10-16 EP claimed
US-20130253084-A1 POLYURETHANE ELASTOMERS MADE USING MIXTURES OF ALIPHATIC DIOL CHAIN EXTENDER AND SECONDARY AMINE DOW GLOBAL TECHNOLOGIES LLC. 2013-09-26 US claimed
WO-2012078322-A1 POLYURETHANE ELASTOMERS MADE USING MIXTURES OF ALIPHATIC DIOL CHAIN EXTENDER AND SECONDARY AMINE DOW GLOBAL TECHNOLOGIES LLC (US) 2012-06-14 WO claimed
US-4797504-A HYDROXYLAMINES AND PHENYLENEDIAMINE DERIVATIVES BETZ LABORATORIES, INC. (US) 1989-01-10 US claimed
EP-0266906-A2 Method and composition for inhibiting acrylate ester polymerization BETZ EUROPE, INC. (US) 1988-05-11 EP claimed
US-4720566-A Method and composition for inhibiting acrylonitrile polymerization BETZ LABORATORIES, INC. (US) 1988-01-19 US claimed
WO-2026104847-A1 USES AND COMPOSITIONS COMPRISING POLYAMIDES INNOSPEC LIMITED (GB) 2026-05-21 WO disclosed
WO-2026104834-A1 USE OF A NITROGEN CONTAINING COMPOUND WITH INCREASED WATER REPELLENCY, REDUCED FRICTION, OR IMPROVED VISUAL APPEARANCE, METHOD OF TREATING A SURFACE, COMPOSITION AND TREATED SUBSTRATE INNOSPEC LIMITED (GB) 2026-05-21 WO disclosed
WO-2026104838-A1 POLYAMIDES AND CONCENTRATE COMPOSITIONS COMPRISING THE POLYAMIDES INNOSPEC LIMITED (GB) 2026-05-21 WO disclosed
US-20260078098-A1 PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES SUPERNUS PHARMACEUTICALS, INC. (US) 2026-03-19 US disclosed
US-20250109343-A1 CORROSION INHIBITOR INNOSPEC LIMITED (GB) 2025-04-03 US disclosed
US-4720566-A Method and composition for inhibiting acrylonitrile polymerization BETZ LABORATORIES, INC. (US) 1988-01-19 US disclosed
EP-0240297-A1 Inhibiting polymerization of vinyl aromatic compounds BETZ EUROPE, INC. (US) 1987-10-07 EP disclosed
US-4251660-A Method for preparing tetrahydroisoquinolines SMITHKLINE CORPORATION (US) 1981-02-17 US disclosed
US-4251660-A Method for preparing tetrahydroisoquinolines SMITHKLINE CORPORATION (US) 1981-02-17 US disclosed
US-4056558-A Sulfosuccinates of polyhydroxy tertiary amines as new detergent-softener compounds COLGATE-PALMOLIVE COMPANY (US) 1977-11-01 US disclosed
US-4045560-A ANTIDEPRESSANTS SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078098-A1 PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES HTR2C, SLC6A2, HTR1D TSHR 260/4885CNR2 54/4885LMNA 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.